Bluejay Diagnostics, Inc. (BJDX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-114.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $249.0K | — | — | — |
| Cost of Revenue | — | — | — | $200.1K | — | — | — |
| Gross Profit | — | — | — | $48.9K | — | — | — |
| Operating Income | -$6.95M | -$7.17M | -$10.31M | -$9.32M | -$3.23M | -$1.20M | — |
| Net Income | -$6.85M | -$7.72M | -$9.95M | -$9.30M | -$3.49M | -$1.16M | — |
| EPS (Diluted) | $-15.25 | $-456.75 | $-3631.48 | $-9.22 | $-0.41 | — | — |
| Total Assets | $7.12M | $6.66M | $4.87M | $13.52M | $21.02M | $1.52M | — |
| Total Liabilities | $1.14M | $927.9K | $1.97M | $1.98M | $637.2K | $1.85M | — |
| Shareholders' Equity | $5.98M | $5.73M | $2.89M | $11.54M | $20.38M | -$4.21M | -$2.93M |
| Cash & Equivalents | $5.16M | $4.30M | $2.21M | $10.11M | $19.05M | $912.4K | — |
| Operating Cash Flow | -$6.05M | -$7.82M | -$8.31M | -$7.74M | -$4.37M | -$508.7K | — |
| Capital Expenditures | $173.7K | $306.8K | $704.2K | $1.20M | $23.9K | — | — |
| Shares Outstanding | 604.5K | 138.5K | 3.1K | 1.01M | 20.11M | 3.15M | — |